Bacterial vaginosis (BV) is a common gynecological infection. BV is caused when the “good” and “bad” bacteria that naturally live in the vagina become out of balance. Some women will have no symptoms of a BV infection, but others may experience itching, irritation, and abnormal discharge. BV is not a sexually transmitted infection (STI), but when left untreated it can increase the risk of contracting other STIs including chlamydia, HPV, and HIV.
A new study from Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Medicine at Mount Sinai looked at the vaginal microbiome of young women to try to better understand the link between BV and STIs. It found that there are two distinct types of BV infection, one of which increases the risk of chlamydia infection. The researchers think this discovery could one day change how we screen for and treat BV.
Researchers recruited 560 adolescent and young adult women who were Black or Latina. Both BV and chlamydia are more common among women in these communities. They took samples of vaginal and cervical fluid from participants who did not have chlamydia, from those who had a current infection, and from those who had recently been treated with antibiotics. DNA sequencing of the samples allowed them to identify the two types of BV.
Dr. Robert Burk, who served as co-lead on this study, explained, “This research shows that specific changes in the cervicovaginal microbiome set the stage for chlamydia. And it shows that targeting treatment against the more-dangerous BV subtype could potentially prevent many women from developing chlamydia, which is particularly prevalent in historically underserved communities.”
Health care providers don’t yet have the technology to test for which type of BV a person has, but Burk and his colleagues envision a future where there is more regular testing for BV and high-risk types are treated immediately. “We can now determine which BV cases are most worrisome and should be closely monitored. Detecting and treating these infections could substantially reduce the incidence of chlamydia and its serious consequences including pelvic inflammatory disease, infertility, and miscarriage,” Burk explained.
More research has to be done, however, before this can become the standard for testing and treatment.
In the meantime, it’s important for women to see a provider whenever they have symptoms of vaginal itching, burning, or irritation. It could be a yeast infection, BV, or an STI such as chlamydia or gonorrhea. Getting diagnosed and treated as soon as possible can relieve symptoms, prevent long-term complications, and help stop the spread of STIs.
It’s also important that people who are sexually active get regularly tested for STIs like chlamydia or gonorrhea because they often have no symptoms. The CDC recommends, for example, that sexually active young women under 25 get screened for chlamydia at least once each year.
The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.
The results of large-scale study of HPV suggest that one shot of the vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
There are several awareness observations each May, including Women’s Health Month, Sex Ed for All Month, and Hepatitis Awareness Month.
Many people who take doxy PEP say it gives them peace of mind in their relationships and sex life. We sat down with Oscar Alexis, Efthimios, and Maxfield Haynes to talk about doxy PEP and get their perspective.
When we talk about contraception, we usual think about things that we can get from our doctors or pharmacists, but the truth is preventing pregnancy can be a simple as changing your behavior.
Non-hormonal contraceptive methods fall into a few categories. These include barrier methods and surgical options.
About 1.6 million cases of chlamydia and 600,000 cases of gonorrhea are diagnosed in the United Sates each year. A new study suggests that these patients may not be following through with STI treatment or getting the right antibiotics.
A clinical trial of a new antibiotic found that it works just as well as a current drug regimen for treating gonorrhea infections. This is important because the bacteria that causes gonorrhea has become resistant to most existing antibiotics.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2025 American Sexual Health Association